Home » Topics » Regulatory

Regulatory
RSS

Avastin approved with chemotherapy for first-line treatment of NSCLC

Oct. 13, 2006

Risperdal approved for irritability associated with autistic disorder

Oct. 9, 2006

Brovana approved for COPD

Oct. 9, 2006

Zolinza approved for cutaneous manifestations in CTCL patients

Oct. 9, 2006

Vectibix approved for metastatic colorectal cancer

Sep. 28, 2006

Lamictal approved for new epilepsy indication

Sep. 26, 2006

Idenix receives first approval for novel CHB treatment

Sep. 21, 2006

Lyrica indications broadened in E.U. to include central neuropathic pain

Sep. 19, 2006

Glivec approved in E.U. for additional cancer indications

Sep. 19, 2006

FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus

Sep. 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...